TABLE 1.
Demographic and Clinical Characteristics Among Older Breast Cancer Survivors and Frequency‐Matched Noncancer Controls
| Demographic and Clinical Variables | No. (%) | P a | |
|---|---|---|---|
| Survivors, n = 262 | Controls, n = 165 | ||
| Age: Mean ± SD, y | 67.9 ± 5.3 | 68.0 ± 6.0 | .834 |
| Race | .274 | ||
| Non‐White | 40 (15.3) | 19 (11.5) | |
| White | 222 (84.7) | 146 (88.5) | |
| Marital status | .184 | ||
| Married or living as married | 156 (64.2) | 91 (57.6) | |
| Other | 87 (35.8) | 67 (42.4) | |
| Education: Mean ± SD, y | 15.6 ± 2.2 | 15.8 ± 2.1 | .361 |
| Employment status | .630 | ||
| Currently employed | 85 (35.0) | 59 (37.3) | |
| Not currently employed | 158 (65.0) | 99 (62.7) | |
| Year of study enrollment | <.001 | ||
| 2014 | 4 (1.5) | 2 (1.2) | |
| 2015 | 31 (11.8) | 1 (0.6) | |
| 2016 | 23 (8.8) | 9 (5.5) | |
| 2017 | 44 (16.8) | 57 (34.5) | |
| 2018 | 90 (34.4) | 47 (28.5) | |
| 2019 | 50 (19.1) | 48 (29.1) | |
| 2020 | 20 (7.6) | 1 (0.6) | |
| AJCC Cancer stage | — | ||
| 0 | 55 (21.8) | — | |
| I | 152 (60.3) | — | |
| II | 40 (15.9) | — | |
| III | 5 (2.0) | — | |
| Treatment group | — | ||
| Chemotherapy | 51 (19.5) | — | |
| Hormonal therapy | 211 (80.5) | — | |
| County COVID‐19 death rate: Mean ± SD | 0.8 ± 0.9 | 0.9 ± 0.8 | .714 |
| Time from the last pre–COVID‐19 assessment to the COVID‐19 survey: Mean ± SD, mo | 10.6 ± 5.6 | 10.4 ± 3.8 | .630 |
Abbreviation: COVID‐19, coronavirus disease 2019.
a
P values were derived from t tests or χ2 tests.